Athanasios Tsiatis

Company: ALX Oncology
Job title: Senior Vice President - Clinical Development
Seminars:
Combining Targeted Agents with Checkpoint Inhibitors 5:00 pm
• Delving into PD-L1 combination studies • Understanding rationale depending on drug pathology • Clinical data comparisons • Relevance to treatment regimes and study designRead more
day: Day One